BiowavePRO is an electronic neuromodulation pain therapy system focused on blocking pain non-invasively. This allows a greater range of motions in recipients and is designed for use among athletes and in pain clinic settings. The BiowavePRO is approved by the FDA.
Related Articles on Pain Management:
Countermeasures Suggested After Rise in Opioid-Related Deaths
Study Examines Major Differences Between Chronic, Subacute Pain
Norwood Hospital Opens Pain Management Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.